Eight stocks where retail holding surged in Q4 as MFs & FIIs sold

One of the biggest retail bets of the quarter was Majesco, where retail holding jumped by a whopping 39.65 percentage points to 60.79 per cent from 21.14 per cent at the end of December quarter. Both FPIs and mutual funds dumped the stock during t...

iStock
Recent debutant Burger King India also saw retail buying, even as the scrip has lost one-fourth of its value year to date.
NEW DELHI: Even as the second wave of Covid-19 halted the market momentum from the middle of the March quarter, one set of companies saw retail investors buy into them heavily, latest shareholding data showed.

At least 45 companies from an initial set of 700 stocks (BSE500, BSE Midcap and BSE Smallcap indices) saw retail holding rise by 200 basis points, or higher, during the March quarter. At least eight companies saw retail holdings spike by at least 500 basis points and up to 4,000 basis points!

One of the biggest retail bets of the quarter was Majesco, where retail holding jumped by a whopping 39.65 percentage points to 60.79 per cent from 21.14 per cent at the end of December quarter. Both FPIs and mutual funds dumped the stock during the period.


The scrip has soared a solid 374 per cent in 2021 so far, as realtor Aurum Ventures acquired 14.78 per cent stake in the IT consulting and software company, and followed it up by announcing an open offer to buy another 26 per cent stake.

Retail shareholding in Himadri Specialty Chemical jumped by 11.97 percentage points to 34.04 per cent from 22.07 per cent a quarter ago, as Bain Capital cut its stake in the company during the quarter to 11.5 per cent from 24.64 per cent a quarter ago. The scrip is down 4 per cent year to date. The company's December quarter profit rose a mere 3 per cent. The company recently decided to permanently close a manufacturing unit in Gujarat on expiring of the lease.

10 stocks that may deliver solid returns in the next few weeks
1/11

As Covid caseload is rising non-stop, the market has also been under pressure, with one-third of BSE500 stocks under bear grip. But that doesn’t mean you can not make money in the market. "Due to the Covid second wave impact, India has been an underperformer in April. But this has the potential to reverse when the Covid graph peaks & declines. There is safety in IT & pharma stocks which will do well irrespective of the disruptions," Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services, said.



Here are 10 stocks that analysts recommend may deliver strong returns in the next few weeks.

As Covid caseload is rising non-stop, the market has also been under pressure, with one-third of BSE500 stocks under bear grip. But that doesn’t mean you can not make money in the market. "Due to the..
Read More

Sun Pharma Advanced Research is currently making an attempt to stage an upside breakout of its key resistance level at Rs 166 (resistance as per change in polarity). The 14-week RSI shows a positive indication. The analyst recommends traders to buy Sun Pharma at CMP of Rs 164.90, add more on dips down to Rs 158 and wait for an upside target of Rs 182 in the next 3-4 weeks. Place a stop loss at Rs 155.



(Analyst: Nagaraj Shetti, Technical Research Analyst, HDFC Securities)

Sun Pharma Advanced Research is currently making an attempt to stage an upside breakout of its key resistance level at Rs 166 (resistance as per change in polarity). The 14-week RSI shows a positive ..
Read More

A strong upside breakout made in early April is still intact and the stock is now poised for a decisive upside breakout of its next key overhead resistance around Rs 2,650. Volume and RSI indicators show positive indication. Traders may buy PI Industries at CMP at Rs 2,560, add more on dips down to Rs 2,450 and wait for the upside target of Rs 2,825 in the next 3-4 weeks, says the analyst. He recommends placing a stop loss at Rs 2,390.



(Analyst: Nagaraj Shetti, Technical Research Analyst, HDFC Securities)

A strong upside breakout made in early April is still intact and the stock is now poised for a decisive upside breakout of its next key overhead resistance around Rs 2,650. Volume and RSI indicators ..
Read More

The top of March 2021 was on deteriorating volumes. Price has seen a deterioration of around 12-13 per cent from the top. On the way down we see prices declining with an increase in volumes. Directional movement index is showing a sell signal as MACD line has also turned bearish. Grasim had closed below its 50-period moving average. It is time to exit out of the stock as the price could see a potential decline to Rs 1,110 and below this to Rs 900 over the next couple of weeks, recommends the analyst.



(Analyst: Manish Shah, Trader and Trading Coach, Niftytriggers.com)

The top of March 2021 was on deteriorating volumes. Price has seen a deterioration of around 12-13 per cent from the top. On the way down we see prices declining with an increase in volumes. Directio..
Read More

On the weekly time frame chart, Orient Refractories has seen a breakout of a massive right angled triangle. This could be a very bullish development. A breakout of a four-year-old ascending triangle is a condition to watch out for and this can trigger a massive rally in the stock. The moving averages are bullish and both the 20-week averages and 50-week averages are also bullish. The analyst has a buy recommendation on the stock for a target price of Rs 325 and above that to Rs 360 over the next 6-8 weeks. Keep a stop below Rs 250.



(Analyst: Manish Shah, Trader and Trading Coach, Niftytriggers.com)

On the weekly time frame chart, Orient Refractories has seen a breakout of a massive right angled triangle. This could be a very bullish development. A breakout of a four-year-old ascending triangle ..
Read More

The stock is currently placed at the lower band of the rising channel, that is in place since September 2020, and the rising 50-day EMA. The analyst expects the stock to maintain its rhythm of higher base at its 50-day EMA and resume the primary up trend after last one week's corrective decline. TCS offers a fresh entry opportunity with a favourable risk reward set up. The analyst expects the stock to retest its all-time high of Rs 3,354 in the coming weeks. He recommends keeping the stop loss at Rs 3,045 on a closing basis.



(Analyst: Harmesh Shah, Head - Technical, ICICIdirect)

The stock is currently placed at the lower band of the rising channel, that is in place since September 2020, and the rising 50-day EMA. The analyst expects the stock to maintain its rhythm of higher..
Read More

The stock is in a secular up trend forming higher peak and higher troughs. It has recently registered a resolute breakout above the rising trendline joining highs of Aug’20 and Feb’21. The weekly MACD recently generated a buy signal, thus validating a positive bias. The analyst expects Cipla to continue with its positive momentum and head towards Rs 1,025 levels. Maintain a stop loss at Rs 905 on a closing basis.



(Analyst: Harmesh Shah, Head - Technical, ICICIdirect)

The stock is in a secular up trend forming higher peak and higher troughs. It has recently registered a resolute breakout above the rising trendline joining highs of Aug’20 and Feb’21. The weekly MAC..
Read More

The stock has witnessed a shallow retracement of the last up move as it took six sessions to retrace just 61.8% of the preceding six sessions' up move, signalling a robust price structure and a higher base formation, thus offering a fresh entry opportunity. The weekly MACD is in uptrend and seen diverging from its 9-period average, supporting a positive bias. The analyst expects Graphite India to head towards Rs 695. Maintain a stop loss at Rs 590 on a closing basis.



(Analyst: Harmesh Shah, Head - Technical, ICICIdirect)



(Image source: Graphiteindia.com)

The stock has witnessed a shallow retracement of the last up move as it took six sessions to retrace just 61.8% of the preceding six sessions' up move, signalling a robust price structure and a highe..
Read More

The stock has reversed from the support of its 200-DMA, leading to a shift in momentum. Indicators like MACD and RSI hint that the momentum in Glenmark is likely to continue. The stock recently gave a breakout of the sideways channel as well. The analyst recommends a buy on Glenmark Pharma with the target of Rs 690. Investors are advised to maintain a stop loss at Rs 440.



(Analyst: Ashis Biswas, Head of Technical Research at CapitalVia Global)

The stock has reversed from the support of its 200-DMA, leading to a shift in momentum. Indicators like MACD and RSI hint that the momentum in Glenmark is likely to continue. The stock recently gave ..
Read More

The stock is currently moving in an uptrend channel. It has been trading above its 200-DMA, indicating a positive outlook on the stock. The analyst expects the momentum to continue in the stock as it has also given a breakout of the triple bottom formation. He recommends a buy with a target of Rs 132 and a stop loss at Rs 75 for a medium-term perspective.



(Analyst: Ashis Biswas, Head of Technical Research at CapitalVia Global)

The stock is currently moving in an uptrend channel. It has been trading above its 200-DMA, indicating a positive outlook on the stock. The analyst expects the momentum to continue in the stock as it..
Read More
Shares of Snowman Logistics have tanked 25 per cent in 2021 so far. Retail investors hiked their stake in the company to 39.07 per cent, up 11.29 percentage points from 27.78 per cent at the end of December. The company has established market position in temperature-controlled logistics, but is exposed to funding risks related to capex, susceptibility to competition and volatility in end-user segments, Crisil said.
ADVERTISEMENT

Recent debutant Burger King India also saw retail buying, even as the scrip has lost one-fourth of its value year to date. Retail investors now own 13.18 per cent in the fast food chain compared with 4.13 per cent at the end of December quarter, up 9.05 percentage points sequentially. Mutual funds and domestic institutions were among the key sellers.

Analysts said weakness in dine-in business and lockdowns in March may lead to negative same-store sale growth (SSSG) in March quarter even on a soft base. They expect the company to report losses for the quarter.

Jain Irrigation Systems (up 7.61 percentage points), Ircon International (up 6.84 percentage points), Care Ratings (5.5 percentage points) and Take Solutions (5.489 percentage points) are out other companies where retail holding jumped materially in the March quarter.

Among them, a rise in retail holding in Care Ratings was at the expense of stake reduction by MFs and FPIs. In the case of Ircon, the government divested 16 per cent stake via an OFS in March quarter. Elara finds Ircon's order book diversified, but the focus hazy.
ADVERTISEMENT

“The management outlook on new inflows also focused on domestic roads and railways as international project finalisations have been delayed due to Covid. Diversification across commercial real estate development, station redevelopment, coal connectivity and solar energy generation projects dilutes focus," it said.

HNIs were among sellers in Jain Irrigations, while in Take Solutions the sellers belonged to the ‘others’ category.
ADVERTISEMENT
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Eight stocks where retail holding surged in Q4 as MFs & FIIs sold
Text Size:AAA
Success
This article has been saved

*

+